News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

IDBS Provides E-WorkBook to Seattle Genetics, Inc. (SGEN)



12/10/2012 1:05:22 PM

London, UK, and Boston, US, December 10, 2012 – IDBS, a global provider of innovative data management, analytics and modeling solutions, today announced that Seattle Genetics, Inc., the leader in antibody-drug conjugate (ADC) development, has selected E-WorkBook.

E-WorkBook supports a broad range of scientific disciplines within one single platform, increasing operational efficiency through secure and flexible management of all research and data. It reduces deployment time and administration, by enabling all experimental data to be available for more efficient analysis and easier sharing. It can also be integrated ‘just in time’ for rapid, informed decision-making.

Neil Kipling, CEO and Founder of IDBS said, "To be able to capture, integrate and retrieve all scientific data in real-time revolutionizes drug R&D as well as producing measurable return on investment. Having the wealth of your scientific information only a click away enables faster, better decision-making. It also allows peer-to-peer collaboration, which is at the core of innovation. This leads to faster progress of good projects, which is the purpose of any R&D organization.”

When supported by top quality data management, workflow and reporting, scientists can focus on the science rather than spending time searching through countless documents. E-WorkBook is proven to help scientists save between five and eight hours a week by enabling users to find data faster, as well as completing projects and reporting quicker.

About IDBS

IDBS is a global provider of innovative enterprise data management, analytics and modeling solutions. The company’s uniquely sophisticated platform technologies are used by more than 200 pharmaceutical companies, major healthcare providers, global leaders in academic study, and high tech companies to increase efficiency, reduce costs and improve the productivity of industrial R&D and clinical research. IDBS is clearly differentiated by its unique combination of award-winning enterprise technologies and domain knowledge in R&D.

IDBS’ solutions help scientists, hospitals and R&D businesses produce the world’s newest therapeutics, diagnostics and personalized treatments, high-tech materials and consumer products, faster, cleaner engines and fuels, breakthroughs in productive agriculture, healthy, safer food products, and high tech materials and products.

Founded in 1989 and privately held, IDBS is headquartered in Guildford, UK with a direct sales and support presence worldwide. IDBS is a Profit Track 100 company and the recipient of multiple awards including the Frost and Sullivan ‘Enabling Technology’ Award in R&D data management and the Queen’s Award for International Trade 2011. Further information can be found at www.idbs.com, or follow us on Twitter @IDBSsoftware.

For further details please contact Metia on behalf of IDBS:

Lyndon Ryan

+4420 3100 3525

idbs@metia.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES